Ascletis Pharma to Host Obesity Portfolio Webinar on April 2, 2025

HONG KONG, March 20, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces it will host an Obesity Portfolio Webinar on April 2, 2025, from 9:00 a.m. – 10:30 a.m. ET.

The event will include a detailed discussion on Ascletis' obesity portfolio including exciting data about its potential best-in-class clinical stage GLP-1R biased small molecule agonist, ASC30, for both once daily oral tablet and once monthly subcutaneous injection administration. Jinzi Jason Wu, Ph.D., Founder, Chairman & CEO of Ascletis, and John Gargiulo, MBA, Chief Business Officer of Ascletis, will host Q&A immediately following the presentation.

Presentation Date: Wednesday, April 2, 2025

Time: 9:00 a.m. – 10:30 a.m. Eastern Time

Registration: To access and attend the virtual event, please register: icr.swoogo.com/Ascletis

An archived replay of the webcast will be available at the same link for 30 days following the event. If you have any questions, please contact Brandon.Weiner@icrhealthcare.com.